Why the study?
The role and mechanisms of Tanshinone IIA in diabetes-induced cardiac dysfunction remained unclear.
Does Tanshinone IIA ameliorate diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress via SIRT1 in diabetic mice?
Does Tanshinone IIA ameliorate diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress via SIRT1 in diabetic mice?
Tanshinone IIA shows protective effects against diabetic cardiomyopathy in preclinical models by modulating endoplasmic reticulum stress via SIRT1.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in diabetic cardiomyopathy; hypothesis-generating for SIRT1-ERS modulation in animal models.
Diabetic cardiomyopathy (DCM) is a common complication in patients with diabetes, and ultimately leads to heart failure. Endoplasmic reticulum stress (ERS) induced by abnormal glycolipid metabolism is a critical factor that affects the occurrence and development of DCM. Additionally, the upregulation/activation of silent information regulation 2 homolog-1 (SIRT1) has been shown to protect against DCM. Tanshinone II A (Tan IIA), the main active component of Salviae miltiorrhizae radix et rhizome (a valuable Chinese medicine), has protective effects against cardiovascular disease and diabetes. However, its role and mechanisms in diabetes-induced cardiac dysfunction remain unclear. Therefore, we explored whether Tan IIA alleviates ERS-mediated DCM via SIRT1 and elucidated the underlying mechanism. The results suggested that Tan IIA alleviated the pathological changes in the hearts of diabetic mice, ameliorated the cytopathological morphology of cardiomyocytes, reduced the cell death rate, and inhibited the expression of ERS-related proteins and mRNA. The SIRT1 agonist inhibited the activities of glucose-regulated protein 78 (GRP78). Furthermore, the opposite results under the SIRT1 inhibitor. SIRT1 knockdown was induced by siRNA-SIRT1 transfection, and the degree of GRP78 acetylation was increased. Cumulatively, Tan IIA ameliorated DCM by inhibiting ERS and upregulating SIRT1 expression.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: